Citigroup Inc.
NYSE:CBanks - Diversified
+$0.24 today
- Market cap
- $194.16B
- Beta
- 1.11
- P/E (TTM)
- 15.6
- EPS (TTM)
- $9.21
- Dividend yield
- 1.67%
Volume 10.45M
Average 12.37M
C Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Citigroup Inc.NYSE: C
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How C compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for C, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | ¥0 JPY | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| Peer median (excluding C) | — | — | — | 0.0% | |
Competitors are the stored peer set for C. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 79.87B | 100.22B | 155.38B | 170.71B | 168.29B |
| Cost of Revenue | 4.09B | 30.85B | 87.48B | 99.59B | 93.24B |
| Gross Profit | 75.78B | 69.37B | 67.9B | 71.12B | 75.05B |
| Gross Margin | 94.9% | 69.2% | 43.7% | 41.7% | 44.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 26.74B | 28.31B | 30.71B | 29.75B | 30.82B |
| Operating Expenses | 48.31B | 50.56B | 54.99B | 54.07B | 55.22B |
| Depreciation & Amortization | 3.96B | 4.26B | 4.56B | 4.31B | 4.37B |
| EBITDA | 31.43B | 23.07B | 17.47B | 21.36B | 24.2B |
| EBITDA Margin | 39.4% | 23.0% | 11.2% | 12.5% | 14.4% |
| Operating Income | 27.47B | 18.81B | 12.91B | 17.05B | 19.83B |
| Operating Margin | 34.4% | 18.8% | 8.3% | 10.0% | 11.8% |
| Interest Income | 50.48B | 74.41B | 133.26B | 143.71B | 142.86B |
| Interest Expense | 7.98B | 25.74B | 78.36B | 89.62B | 83.07B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 27.47B | 18.81B | 12.91B | 17.05B | 19.83B |
| Pre-Tax Margin | 34.4% | 18.8% | 8.3% | 10.0% | 11.8% |
| Income Tax Expense | 5.45B | 3.64B | 3.53B | 4.21B | 5.37B |
| Net Income | 21.95B | 14.85B | 9.23B | 12.68B | 14.31B |
| Net Margin | 27.5% | 14.8% | 5.9% | 7.4% | 8.5% |
| EPS (Basic) | 10.21 | 7.04 | 4.07 | 6.03 | 7.23 |
| EPS (Diluted) | 10.14 | 7.00 | 4.04 | 5.95 | 6.99 |
| Weighted Avg Shares | 2.03B | 1.95B | 1.93B | 1.9B | 1.82B |
| Weighted Avg Shares (Diluted) | 2.05B | 1.96B | 1.96B | 1.9B | 1.86B |
Citigroup Inc.
NYSE:C
Intrinsic Alpha fair value
Locked
Current Price
$117.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.